We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Crown Holdings
CCK
$12.8B
| – | – |
-271,559
| Closed | -$12.2M |
|
1002
C.H. Robinson
CHRW
$17.4B
| – | – |
-5,455
| Closed | -$286K |
|
1003
Charter Communications
CHTR
$17.3B
| – | – |
-114,276
| Closed | -$14.1M |
|
1004
Cigna
CI
$73.7B
| – | – |
-275,198
| Closed | -$23.6M |
|
1005
CEMIG Preferred Shares
CIG
$6.26B
| – | – |
-395,564
| Closed | -$1.37M |
|
|
CIVI
1006
CALL
DELISTED
Civitas Resources
CIVI
| – | – |
-54
| Closed | -$267K |
|
1007
Celldex Therapeutics
CLDX
$2.99B
| – | – |
-3,633
| Closed | -$820K |
|
1008
Comcast
CMCSA
$85B
| – | – |
-14,842
| Closed | -$381K |
|
1009
Chipotle Mexican Grill
CMG
$47.2B
| – | – |
-1,534,800
| Closed | -$17.4M |
|
1010
Centene
CNC
$30.7B
| – | – |
-24,748
| Closed | -$385K |
|
1011
Cinemark Holdings
CNK
$4.24B
| – | – |
-29,176
| Closed | -$846K |
|
1012
CONMED
CNMD
$1.39B
| – | – |
-15,212
| Closed | -$661K |
|
1013
Columbia Sportswear
COLM
$3.04B
| – | – |
-73,824
| Closed | -$3.05M |
|
1014
ConocoPhillips
COP
$147B
| – | – |
-458,728
| Closed | -$35.7M |
|
1015
Cencora
COR
$60.6B
| – | – |
-29,327
| Closed | -$1.92M |
|
1016
CALL
Copart
CPRT
$27B
| – | – |
-133,600
| Closed | -$607K |
|
|
1017
PUT
Copart
CPRT
$27B
| – | – |
-182,400
| Closed | -$830K |
|
1018
PUT
Capri Holdings
CPRI
$1.83B
| – | – |
-2,400
| Closed | -$224K |
|
1019
Cirrus Logic
CRUS
$6.53B
| – | – |
-23,770
| Closed | -$472K |
|
1020
Canadian Solar
CSIQ
$1.02B
| – | – |
-14,006
| Closed | -$378K |
|
|
CTRA
1021
DELISTED
Coterra Energy
CTRA
| – | – |
-999,808
| Closed | -$33.9M |
|
1022
Cognizant
CTSH
$24.9B
| – | – |
-34,005
| Closed | -$1.72M |
|
1023
CALL
Chevron
CVX
$392B
| – | – |
-22,400
| Closed | -$2.66M |
|
1024
Community Health Systems
CYH
$393M
| – | – |
-311,448
| Closed | -$10.1M |
|
1025
Daktronics
DAKT
$955M
| – | – |
-18,568
| Closed | -$268K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.